Emergent Biosolutions

Founded in 1998, Emergent Biosolutions’s history has been one of innovation and growth. It stays true to its mission: to protect and enhance life. 

Emergent is a manufacturer of the only FDA-approved anthrax vaccine, BioThrax, and is a major supplier to the US government. This has enabled the company to expand into other therapeutic areas.

In 2014, Emergent acquired Cangene Corporation, bringing over 70 years of experience in researching and marketing to the company. These new skills gave Emergent a better understanding of lifesaving therapies for treatment of rare diseases, blood disorders, and medical countermeasures for biodefense.

Contact Info

155 Innovation Drive Winnipeg R3T 5Y3 MB Canada
P: 1 204 275 4200



Emergent BioSolutions is currently seeking a Manager, Engineering. The select candidate will possess a University degree in Engineering, have 3+ years’ experience in management within the field of Engineering in the pharmaceutical cGMP industry. This can…

Read More

Emergent BioSolutions is currently seeking a Project Manager, (Project Specialist), in our Project Management Department. The successful candidate will have post-secondary education preferably in Business or Science related fields, a minimum of 2 years o…

Read More


Emergent BioSolutions is currently seeking an Associate Project Specialist in our Project Management Department. The successful candidate will have a minimum of post-secondary education, preferably in Business or a Science r…

Read More

Latest News

Raising Kane: Biotech on rebound

With about 70 patents, series of fundings, and an innovative product line, primarily to address the prevention and removal of microbial biofilms, finally the 19-year-old company makes it big in the bioscience industry!


Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.